AstraZeneca, Summit Therapeutics, Ivonescimab, SMT112, AK112, PD-1, VEGF, Bispecific Antibody, Immuno-Oncology, Oncology, NSCLC, Non-Small Cell Lung Cancer

MIAMI — October 5, 2026 Summit Therapeutics Inc. announced the successful closing of a $2.0 billion strategic equity investment...